Global Molecular Diagnostics Market Report: 2014 Edition
Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular,
have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in
order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have
earned the title of ‘silent champion’ of the healthcare industry since this segment influences more than half of the decision-making in the overall
healthcare industry. Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level, and
thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or
disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity and thus, have been
receiving greater inclination from physicians and affiliates. The molecular diagnostics procedures for infectious diseases including CT/NG, HPV; encompasses
four major disciplines: Virology, Bacteriology, Genetics and Blood Screening. Due to certain underlying factors, the oncology segment of the market is poised to
undergo noteworthy expansion in the near future and thereby driving the molecular diagnostics market on the holistic basis. As of now, the global molecular
diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of oncology and reimbursement trend.
The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides detailed information pertaining to its
superset...